rss
Br J Ophthalmol 2006;90:773-777 doi:10.1136/bjo.2005.086520
  • Laboratory science - Extended reports

Frequent immune response to a melanocyte specific protein KU-MEL-1 in patients with Vogt-Koyanagi-Harada disease

  1. S Otani1,2,
  2. T Sakurai1,
  3. K Yamamoto1,
  4. T Fujita1,
  5. Y Matsuzaki1,
  6. Y Goto1,
  7. Y Ando3,
  8. S Suzuki3,
  9. M Usui2,
  10. M Takeuchi2,
  11. Y Kawakami1
  1. 1Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  2. 2Department of Ophthalmology, Tokyo Medical University, Shinjuku-ku, Tokyo, Japan
  3. 3Department of Ophthalmology, Keio University School of Medicine, Shinjuku-ku, Tokyo, Japan
  1. Correspondence to: Yutaka Kawakami MD, PhD, Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, 35 Shinanomachi, Shinjyukuku, Tokyo, 160-8582, Japan; yutakawa{at}sc.itc.keio.ac.jp
  • Accepted 2 February 2006
  • Published Online First 15 February 2006

Abstract

Aim: To isolate autoantigens possibly involved in the pathogenesis of Vogt-Koyanagi-Harada (VKH) disease.

Methods: Autoantigens recognised by immunoglobulin G antibodies (IgG Ab) in sera from VKH patients were isolated by screening the lambda phage cDNA libraries made from melanocytes and a highly pigmented melanoma cell line with the patients’ sera. Presence of IgG specific for the autoantigens in sera from patients with various panuveitis and healthy individuals was evaluated. Relation between the specific IgG and various clinicopathological features was examined.

Results: KU-MEL-1 was found to be one of the 81 isolated positive clones representing 35 distinct genes, which is a previously isolated melanoma antigen preferentially expressed in melanocytes. The IgG Ab specific for KU-MEL-1 was detected in sera from patients with VKH in significantly higher amounts than in sera from patients with Behçet’s disease, sarcoidosis, and from healthy individuals. Positive serum KU-MEL-1 Ab was significantly associated with HLA-DRB1*0405 and male VKH patients.

Conclusion: KU-MEL-1 was identified as a new autoantigen for VKH. The highly frequent induction of IgG Ab for KU-MEL-1 in HLA-DRB1*0405 positive VKH patients may suggest the possible involvement of KU-MEL-1 specific CD4+ T cells in the pathogenesis of VKH, suggesting the possible use in the development of diagnostic and therapeutic treatments for VKH patients.

Footnotes

    This Article

    1. Abstract
    2. Full text
    3. PDF
    4. All Versions of this Article:
      1. bjo.2005.086520v1
      2. 90/6/773 most recent

    Responses

    1. Submit a response
    2. No responses published

    Social bookmarking

    Register for free content


    Free sample
     This recent issue is free to all users to allow everyone the opportunity to see the full scope and typical content of BJO.
    View free sample issue >>

    Free archive
    The full back archive is now available for BJO. Institutional subscribers may access the entire archive as part of their subscription. Personal subscribers will also have access to all content when logged in. Non-subscribers who register have free access to all articles published before 2006, back to volume 1 issue 1.
    Register to access the free archive >>

    Don't forget to sign up for content alerts so you keep up to date with all the articles as they are published.